At Amiro Invest, we invest intensively in new technologies in the field of Cannabis. 
The last two such examples are investments in technology for obtaining HU-331 and CBG + CBD distillates, which are found to have medicinal effects. Both technologies enable distillate to be obtained on a completely natural basis without chemicals at any stage of the process. In the case of HU-331, in the first stage of the resin processing process - the raw material is turned into a distillate - up to 70% CBD concentrate. The distillate is the basis for the continuation of the process in obtaining the CBDHQ product.

We are also offering technology transfer for such extraction of HU-331.
You can read more about HU-331 and its potential medicinal effects here:




You can read more about CBG + CBD and its potential medicinal effects here:
This link describes the potential healing effect against brain cancer - Glioblastoma 

Cannabidiol oxidation product HU-331 is a potential anticancer cannabinoid-quinone: a narrative review

Cannabigerol Is a Potential Therapeutic Agent in a Novel Combined Therapy for Glioblastoma